Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium

Journal of Cardiac Failure

Volumn 2, Issue 4, 1996, Pages 285-292

  Gutstein, David E ^a   Flemmal, Kristen ^a   Bruce, Erika ^a   Travers, Kerry E ^a   Gwathmey, Judith K ^a   Ransil, Bernard J ^a   Markis, John E ^a   Grossman, William ^a   Morgan, James P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Acetylstrophanthidin; Beta adrenergic system; Heart failure; Phosphodiesterase inhibitor

Indexed keywords

ACETYLSTROPHANTHIDIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; DRUG DERIVATIVE; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MILRINONE; PHOSPHODIESTERASE INHIBITOR; PYRIDONE DERIVATIVE; STROPHANTHIDIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CONGESTIVE HEART FAILURE; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECT; HEART CONTRACTION; HEART TRANSPLANTATION; HUMAN; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; REFERENCE VALUE;

1-METHYL-3-ISOBUTYLXANTHINE; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALYSIS OF VARIANCE; CARDIOTONIC AGENTS; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; ISOPROTERENOL; MIDDLE AGED; MILRINONE; MYOCARDIAL CONTRACTION; PHOSPHODIESTERASE INHIBITORS; PYRIDONES; REFERENCE VALUES; STROPHANTHIDIN;

EID: 0030344876     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(96)80015-7     Document Type: Article

References (10)

1. Scholz H: Inotropic drugs and their mechanisms of action. J Am Coll Cardiol 1984;4:389-97
2. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP: Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75:331-9
3. Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK: Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990;81(2, suppl):III21-32
4. Morgan JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 1991:325:625-32
5. Ginsburg R, Bristow MR, Billingham ME, Stinson EB, Schroeder JS, Harrison DC: Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J 1983;106:535-40
6. Wilmshurst PT, Walker JM, Fry CH, Mounsey JP, Twort CH, Williams BT, Davies MJ, Webb-Peploe MM: Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res 1984;18:302-9
7. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB: Decreased catecholamine sensitivity and betaadrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-11
8. Ohsuzu F, Katsushika S, Akanuma M, Hadamada H, Maie S, Muneoka K, Okumori M, Nakamura H: Reduction of beta-adrenergic receptors in atrial cell membranes of patients following mild to moderate heart failure. Jpn Heart J 1994;35:27-34
9. Fowler MB, Laser JA, Hopkins GE, Minobe W, Bristow MR: Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986;74:1290-302
10. Schwinger RH, Bohm M, Erdmann E: Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" beta-adrenoceptors. J Cardiovasc Pharmacol 1990;15:692-7